vs
Artisan Partners Asset Management Inc.（APAM）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
Artisan Partners Asset Management Inc.的季度营收约是Ascendis Pharma A/S的1.3倍（$335.5M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 12.9%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 12.7%）
阿蒂森伙伴资产管理公司（Artisan Partners）是总部位于美国威斯康星州密尔沃基的资产管理机构，除美国本土外，还在都柏林、香港、伦敦、新加坡、悉尼设有办公室，为全球客户提供专业的资产管理服务。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
APAM vs ASND — 直观对比
营收规模更大
APAM
是对方的1.3倍
$267.3M
营收增速更快
ASND
高出29.4%
12.9%
两年增速更快
ASND
近两年复合增速
12.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.5M | $267.3M |
| 净利润 | $118.1M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | 39.2% | — |
| 净利率 | 35.2% | — |
| 营收同比 | 12.9% | 42.3% |
| 净利润同比 | 34.9% | — |
| 每股收益（稀释后） | $1.36 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APAMASND
| Q4 25 | $335.5M | $267.3M | ||
| Q3 25 | $301.3M | $230.7M | ||
| Q2 25 | $282.7M | $170.7M | ||
| Q1 25 | $277.1M | $109.0M | ||
| Q4 24 | $297.1M | $187.8M | ||
| Q3 24 | $279.6M | $62.5M | ||
| Q2 24 | $270.8M | $38.9M | ||
| Q1 24 | $264.4M | $103.6M |
净利润APAMASND
| Q4 25 | $118.1M | — | ||
| Q3 25 | $66.8M | $-65.9M | ||
| Q2 25 | $67.6M | $-42.0M | ||
| Q1 25 | $61.1M | $-102.2M | ||
| Q4 24 | $87.5M | — | ||
| Q3 24 | $73.0M | $-107.1M | ||
| Q2 24 | $57.6M | $-118.1M | ||
| Q1 24 | $59.5M | $-141.5M |
毛利率APAMASND
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% | ||
| Q1 24 | — | 92.1% |
营业利润率APAMASND
| Q4 25 | 39.2% | — | ||
| Q3 25 | 33.8% | 5.1% | ||
| Q2 25 | 28.2% | -33.5% | ||
| Q1 25 | 31.2% | -103.2% | ||
| Q4 24 | 36.7% | — | ||
| Q3 24 | 33.3% | -167.3% | ||
| Q2 24 | 32.0% | -370.2% | ||
| Q1 24 | 29.4% | -51.2% |
净利率APAMASND
| Q4 25 | 35.2% | — | ||
| Q3 25 | 22.2% | -28.5% | ||
| Q2 25 | 23.9% | -24.6% | ||
| Q1 25 | 22.1% | -93.7% | ||
| Q4 24 | 29.5% | — | ||
| Q3 24 | 26.1% | -171.5% | ||
| Q2 24 | 21.3% | -303.9% | ||
| Q1 24 | 22.5% | -136.6% |
每股收益（稀释后）APAMASND
| Q4 25 | $1.36 | — | ||
| Q3 25 | $0.93 | — | ||
| Q2 25 | $0.94 | — | ||
| Q1 25 | $0.82 | — | ||
| Q4 24 | $0.99 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.80 | — | ||
| Q1 24 | $0.84 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $665.3M |
| 总债务越低越好 | $190.0M | — |
| 股东权益账面价值 | $438.8M | $-175.8M |
| 总资产 | $1.6B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资APAMASND
| Q4 25 | — | $665.3M | ||
| Q3 25 | — | $582.2M | ||
| Q2 25 | — | $533.6M | ||
| Q1 25 | — | $559.4M | ||
| Q4 24 | — | $604.3M | ||
| Q3 24 | — | $675.6M | ||
| Q2 24 | — | $279.4M | ||
| Q1 24 | — | $345.9M |
总债务APAMASND
| Q4 25 | $190.0M | — | ||
| Q3 25 | $190.0M | — | ||
| Q2 25 | $200.0M | — | ||
| Q1 25 | $200.0M | — | ||
| Q4 24 | $200.0M | — | ||
| Q3 24 | $200.0M | — | ||
| Q2 24 | $200.0M | — | ||
| Q1 24 | $200.0M | — |
股东权益APAMASND
| Q4 25 | $438.8M | $-175.8M | ||
| Q3 25 | $402.1M | $-188.0M | ||
| Q2 25 | $381.8M | $-202.6M | ||
| Q1 25 | $356.5M | $-205.0M | ||
| Q4 24 | $388.9M | $-114.2M | ||
| Q3 24 | $372.1M | $-105.1M | ||
| Q2 24 | $341.2M | $-346.8M | ||
| Q1 24 | $320.3M | $-257.2M |
总资产APAMASND
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.5B | $819.0M | ||
| Q1 24 | $1.5B | $866.7M |
负债/权益比APAMASND
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.0M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | $171.6M | — |
| 自由现金流率自由现金流/营收 | 51.2% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.46× | — |
| 过去12个月自由现金流最近4个季度 | $420.6M | — |
8季度趋势，按日历期对齐
经营现金流APAMASND
| Q4 25 | $172.0M | $58.2M | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $157.9M | $-15.5M | ||
| Q4 24 | $372.8M | $-330.7M | ||
| Q3 24 | $112.8M | — | ||
| Q2 24 | $75.9M | — | ||
| Q1 24 | $147.0M | $-109.7M |
自由现金流APAMASND
| Q4 25 | $171.6M | — | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $157.7M | — | ||
| Q4 24 | $371.3M | — | ||
| Q3 24 | $112.4M | — | ||
| Q2 24 | $75.2M | — | ||
| Q1 24 | $146.9M | — |
自由现金流率APAMASND
| Q4 25 | 51.2% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 125.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 27.8% | — | ||
| Q1 24 | 55.6% | — |
资本支出强度APAMASND
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.0% | — |
现金转化率APAMASND
| Q4 25 | 1.46× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 2.58× | — | ||
| Q4 24 | 4.26× | — | ||
| Q3 24 | 1.54× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 2.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
